Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$140.06
+0.2%
$133.33
$108.35
$160.27
$39.48B1.252.20 million shs1.62 million shs
Illumina, Inc. stock logo
ILMN
Illumina
$203.01
+2.4%
$178.93
$88.00
$207.00
$29.92B1.451.87 million shs3.10 million shs
Qiagen N.V. stock logo
QGEN
Qiagen
$42.32
0.0%
$39.10
$32.53
$57.81
$8.72B0.632.91 million shs3.36 million shs
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$564.00
-1.7%
$511.34
$435.27
$643.99
$212.25B0.852.22 million shs1.94 million shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
-0.39%-0.88%+6.54%+18.19%+21.17%
Illumina, Inc. stock logo
ILMN
Illumina
+2.45%+5.20%+7.59%+42.38%+106.23%
Qiagen N.V. stock logo
QGEN
Qiagen
+0.16%+0.44%+5.65%+22.89%-19.98%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
-1.71%-2.22%+8.06%+19.14%+20.77%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$140.06
+0.2%
$133.33
$108.35
$160.27
$39.48B1.252.20 million shs1.62 million shs
Illumina, Inc. stock logo
ILMN
Illumina
$203.01
+2.4%
$178.93
$88.00
$207.00
$29.92B1.451.87 million shs3.10 million shs
Qiagen N.V. stock logo
QGEN
Qiagen
$42.32
0.0%
$39.10
$32.53
$57.81
$8.72B0.632.91 million shs3.36 million shs
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$564.00
-1.7%
$511.34
$435.27
$643.99
$212.25B0.852.22 million shs1.94 million shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
-0.39%-0.88%+6.54%+18.19%+21.17%
Illumina, Inc. stock logo
ILMN
Illumina
+2.45%+5.20%+7.59%+42.38%+106.23%
Qiagen N.V. stock logo
QGEN
Qiagen
+0.16%+0.44%+5.65%+22.89%-19.98%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
-1.71%-2.22%+8.06%+19.14%+20.77%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
2.89
Moderate Buy$159.3513.78% Upside
Illumina, Inc. stock logo
ILMN
Illumina
2.50
Moderate Buy$188.40-7.20% Downside
Qiagen N.V. stock logo
QGEN
Qiagen
2.36
Hold$43.342.43% Upside
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
2.79
Moderate Buy$617.149.42% Upside

Current Analyst Ratings Breakdown

Latest ILMN, QGEN, TMO, and A Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/3/2026
Illumina, Inc. stock logo
ILMN
Illumina
Boost Price TargetHold$190.00 ➝ $205.00
8/3/2026
Illumina, Inc. stock logo
ILMN
Illumina
Boost Price TargetSell$95.00 ➝ $113.00
8/3/2026
Illumina, Inc. stock logo
ILMN
Illumina
UpgradeHoldStrong-Buy
8/3/2026
Illumina, Inc. stock logo
ILMN
Illumina
Reiterated RatingOverweight$200.00 ➝ $225.00
7/31/2026
Illumina, Inc. stock logo
ILMN
Illumina
Boost Price TargetOutperform$170.00 ➝ $230.00
7/31/2026
Illumina, Inc. stock logo
ILMN
Illumina
Reiterated RatingMarket Perform$215.00
7/31/2026
Illumina, Inc. stock logo
ILMN
Illumina
Boost Price TargetBuy$200.00 ➝ $226.00
7/31/2026
Illumina, Inc. stock logo
ILMN
Illumina
Boost Price TargetUnderweight$145.00 ➝ $160.00
7/31/2026
Illumina, Inc. stock logo
ILMN
Illumina
Boost Price TargetOverweight$220.00 ➝ $230.00
7/31/2026
Illumina, Inc. stock logo
ILMN
Illumina
Boost Price TargetHold$192.00 ➝ $210.00
7/27/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Boost Price TargetNeutral$510.00 ➝ $600.00
(Data available from 8/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$6.95B5.69$6.64 per share21.08$23.78 per share5.89
Illumina, Inc. stock logo
ILMN
Illumina
$4.34B7.06$6.88 per share29.51$18.80 per share10.80
Qiagen N.V. stock logo
QGEN
Qiagen
$2.09B4.17$3.40 per share12.43$17.89 per share2.37
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$44.56B4.68$29.87 per share18.88$142.49 per share3.96
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.30B$4.9828.1221.252.4819.55%24.33%12.99%8/26/2026 (Estimated)
Illumina, Inc. stock logo
ILMN
Illumina
$850M$5.3637.8833.392.7918.36%29.84%12.17%N/A
Qiagen N.V. stock logo
QGEN
Qiagen
$424.88M$1.9122.1116.154.2219.16%14.40%8.40%8/5/2026 (Confirmed)
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$6.70B$18.5930.3620.502.3315.04%17.09%8.12%N/A

Latest ILMN, QGEN, TMO, and A Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/26/2026Q3 2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.49N/AN/AN/A$1.84 billionN/A
8/5/2026Q2 2026
Qiagen N.V. stock logo
QGEN
Qiagen
$0.5980N/AN/AN/A$527.50 millionN/A
7/30/2026Q2 2026
Illumina, Inc. stock logo
ILMN
Illumina
$1.23$1.31+$0.08$1.35$1.13 billion$1.16 billion
7/23/2026Q2 2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$5.71$6.03+$0.32$4.68$11.71 billion$11.99 billion
5/27/2026Q2 2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.41$1.49+$0.08$1.20$1.80 billion$1.84 billion
5/7/2026Q1 2026
Qiagen N.V. stock logo
QGEN
Qiagen
$0.54$0.54N/A$0.33$496.15 million$492.32 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.020.73%+6.58%20.48%9 Years
Illumina, Inc. stock logo
ILMN
Illumina
N/AN/AN/AN/AN/A
Qiagen N.V. stock logo
QGEN
Qiagen
$0.350.83%N/A18.32%N/A
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$1.880.33%+14.34%10.11%8 Years

Latest ILMN, QGEN, TMO, and A Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/9/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
quarterly$0.470.36%9/15/20269/15/202610/15/2026
5/20/2026
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
quarterly$0.25500.77%6/30/20266/30/20267/22/2026
5/20/2026
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
quarterly$0.470.4%6/15/20266/15/20267/15/2026
5/11/2026
Qiagen N.V. stock logo
QGEN
Qiagen
annual$0.350.9%7/7/20267/7/20267/14/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.43
2.10
1.62
Illumina, Inc. stock logo
ILMN
Illumina
0.53
1.80
1.40
Qiagen N.V. stock logo
QGEN
Qiagen
0.49
3.21
2.57
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.74
1.55
1.18

Institutional Ownership

CompanyInstitutional Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Illumina, Inc. stock logo
ILMN
Illumina
89.42%
Qiagen N.V. stock logo
QGEN
Qiagen
70.00%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
89.23%

Insider Ownership

CompanyInsider Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Illumina, Inc. stock logo
ILMN
Illumina
2.90%
Qiagen N.V. stock logo
QGEN
Qiagen
9.00%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.33%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
18,100282.43 millionN/AOptionable
Illumina, Inc. stock logo
ILMN
Illumina
8,650151.00 million146.91 millionOptionable
Qiagen N.V. stock logo
QGEN
Qiagen
5,654206.07 million187.53 millionOptionable
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
125,000369.75 million370.40 millionOptionable

Recent News About These Companies

3 Cash-Producing Stocks We Think Twice About
Erste Group Bank Has Positive Outlook of TMO FY2026 Earnings

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Agilent Technologies stock logo

Agilent Technologies NYSE:A

$140.06 +0.26 (+0.18%)
As of 09:30 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Illumina stock logo

Illumina NASDAQ:ILMN

$203.27 +5.11 (+2.58%)
As of 09:30 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

Qiagen stock logo

Qiagen NYSE:QGEN

$42.32 -0.02 (-0.04%)
As of 09:30 AM Eastern
This is a fair market value price provided by Massive. Learn more.

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

Thermo Fisher Scientific stock logo

Thermo Fisher Scientific NYSE:TMO

$564.00 -10.03 (-1.75%)
As of 09:30 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.